Mohd Khushman

Medicine & Life Sciences

1. Pancreatic Neoplasms 100%
2. Neoplasms 98%
3. Adenocarcinoma 83%
4. Geriatric Assessment 70%
5. Frailty 54%
6. Exosomes 52%
7. Gastrointestinal Neoplasms 50%
8. gemcitabine 46%
9. Colorectal Neoplasms 44%
10. Neoplasm Metastasis 44%
11. Registries 43%
12. Mutation 36%
13. Survival 35%
14. Microsatellite Instability 32%
15. Tumor Burden 30%
16. Genes 26%
17. Hedgehog Proteins 25%
18. Extracellular Vesicles 25%
19. 130-nm albumin-bound paclitaxel 23%
20. Immunotherapy 23%
21. High-Throughput Nucleotide Sequencing 22%
22. Receptor, Fibroblast Growth Factor, Type 4 22%
23. Pancreatic Stellate Cells 21%
24. honokiol 20%
25. Genotype 20%
26. atezolizumab 20%
27. Immunohistochemistry 20%
28. Neurofibromin 1 20%
29. Meningeal Carcinomatosis 19%
30. Drug Therapy 19%
31. Dihydrouracil Dehydrogenase (NADP) 19%
32. RNA Sequence Analysis 19%
33. Strongyloides stercoralis 18%
34. Bile Duct Neoplasms 18%
35. Receptor-Interacting Protein Serine-Threonine Kinases 18%
36. Biomarkers 18%
37. Anus Neoplasms 18%
38. Therapeutics 17%
39. Adrenomedullin 17%
40. Mortality 17%
41. Vitamin B 12 Deficiency 17%
42. Paraneoplastic Syndromes 17%
43. Microsatellite Repeats 17%
44. Hedgehogs 17%
45. CXC Chemokines 16%
46. Lactic Acidosis 16%
47. Erlotinib Hydrochloride 16%
48. Catenins 16%
49. Hemangiosarcoma 16%
50. Bevacizumab 15%